F3, coagulation factor III, tissue factor, 2152

N. diseases: 456; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0333209
Disease: Platelet thrombus
Platelet thrombus
0.040 Biomarker disease BEFREE Collagen-coated PL-chips, or thromboplastin- and collagen-coated AR-chips, were utilized in the T-TAS to assess platelet thrombus formation at high shear flow, or fibrin-rich platelet thrombus formation at low shear flow, respectively. 31741138 2020
CUI: C0333209
Disease: Platelet thrombus
Platelet thrombus
0.040 Biomarker disease BEFREE The AR-chip coated with collagen and tissue thromboplastin is designed for analysis of the fibrin-rich platelet thrombus formation process under shear stress condition (4 µL/min). 30971637 2019
CUI: C0333209
Disease: Platelet thrombus
Platelet thrombus
0.040 Biomarker disease BEFREE The total thrombus-formation analysis system (T-TAS) was developed for quantitative analysis of platelet thrombus formation by the use of microchips with thrombogenic surfaces (collagen, platelet chip [PL-chip]; collagen plus tissue factor, atherome chip [AR-chip]). 26773298 2016
CUI: C0333209
Disease: Platelet thrombus
Platelet thrombus
0.040 Biomarker disease BEFREE In comparison, incubation of adherent monocytes with the anti-TF MoAb before the blood exposure, reduced the fibrin deposition by 83% (P < .02) and platelet thrombus volume by 75% (P < .0008). 7795226 1995